Atlas Trials

Respiratory Syncytial Virus Infection

33 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Respiratory Syncytial Virus Infection

RecordFirmDate
Efficacy and Safety of Clesrovimab (MK-1654) in Infants (MK-1654-004) (NCT04767373)Merck Sharp & Dohme LLC2021-04-07
Study of an Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers (NCT04491877)Sanofi Pasteur, a Sanofi Company2020-09-17
Molecular and Microbiome/Metagenome Correlates of Recurrent Wheeze in RSV Infected Infants (NCT06424795)University of Rochester2019-12-21
A Safety and Immunogenicity Study of Intranasal Sendai Virus Vectored Respiratory Syncytial Virus (SeVRSV) Vaccine in Healthy Adults (NCT03473002)National Institute of Allergy and Infectious Diseases (NIAID)2018-05-16
A Multicentre Study in Otherwise Healthy Infants and Toddlers Hospitalised For and Diagnosed With RSV Lower Respiratory Tract Infection to Evaluate the Safety, Tolerability, and Clinical Activity of ALX-0171 (NCT02309320)Ablynx, a Sanofi company2014-12-01
Efficacy, Pharmacokinetics, and Safety of Presatovir in Hospitalized Adults With Respiratory Syncytial Virus (RSV) Infection (NCT02135614)Gilead Sciences2014-06-09
Synagis® Liquid 50mg, 100mg for Intramuscular Injection Special Investigation in Immunocompromised Children With Synagis® (NCT02016690)AbbVie2013-12-01
ALX-0171 Safety Study in Adults With Hyperresponsive Airways (NCT01909843)Ablynx, a Sanofi company2013-07-01
Surveillance of Synagis in Korean Pediatric Patients (NCT01537198)AbbVie (prior sponsor, Abbott)2012-01-01
Clinical Study of Palivizumab in Japanese Newborns, Infants and Young Children at the Age of 24 Months or Less With Immunocompromised Medical Conditions (NCT01466062)AbbVie (prior sponsor, Abbott)2011-08-01
A One-Year Observation of Palivizumab in Infants at Risk for Respiratory Syncytial Virus Infection in Latin America (NCT01297504)AbbVie (prior sponsor, Abbott)2011-02-01
Palivizumab for Prevention of Severe Respiratory Syncytial Virus Infection in Russian Children (NCT01006629)Abbott2009-11-01
Effectiveness of Synagis (Palivizumab) Immunoprophylaxis in Preterm Infants With High Risk of Severe Respiratory Syncytial Virus (RSV) Infection (NCT01107535)Abbott2007-09-01
Innate Immunity and Respiratory Syncytial Virus (RSV) Infection in Children (NCT00593918)University of Wisconsin, Madison2003-11-01
Prevention of RSV Infections in Bone Marrow Transplant Recipients (NCT00001903)National Institute of Allergy and Infectious Diseases (NIAID)1999-04-01

Track Respiratory Syncytial Virus Infection automatically

Every clearance here is in the API, with alerts when new ones post.